1 "Patient safety remains our top priority, and, in line with our purpose to improve lives and health, we continue to partner, educate, and advocate for expanded, affordable access to our medicines for those who need and rely on them." In a letter addressed to Novo Nordisk, Jacqueline Corrigan-Curay, JD, MD, acting director for the CDC and FDA, stated, As a result of this review, we conclude that the information and data Novo Nordisk has provided to the FDA demonstrate that Novo Nordisks supply is currently meeting or exceeding demand for its semaglutide injection products and that Novo Nordisk has developed reserves that it now holds in its finished product inventory in addition to significant units of semi-finished product, such that supply will meet or exceed projected demand. 3 The FDA said that there may be intermittent and limited localized supply disruptions due to products moving through the supply chain, but it will not take action against compounders violating the Food, Drug & Cosmetic Act for state-licensed pharmacy or physician compounding under section 503A and for outsourcing facilities under sections 503B until April 22, 2025, and May 22, 2025, respectively

Nick Pifani, a cancer survivor from Delran, said his treatment was informed by biomarker testing
The cost of samples and shipping fees are determined on a case-by-case basis
Being prepared helps
, ,
Individuals who undergo frequent aesthetic treatments such as microneedling, laser, peels, or dermaplaning often find that GHK-Cu peptides significantly reduce downtime, redness, and inflammation while accelerating recovery